Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
antineoplastic agent |
| gptkbp:activeIngredient |
gptkb:vinorelbine
|
| gptkbp:approvedBy |
gptkb:FDA
gptkb:EMA 1994 |
| gptkbp:ATCCode |
L01CA04
|
| gptkbp:brand |
gptkb:vinorelbine
|
| gptkbp:CASNumber |
71486-22-1
|
| gptkbp:chemicalClass |
vinca alkaloid
|
| gptkbp:contraindication |
severe hepatic impairment
severe neutropenia |
| gptkbp:developedBy |
gptkb:Pierre_Fabre
|
| https://www.w3.org/2000/01/rdf-schema#label |
Navelbine
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
inhibits microtubule assembly
|
| gptkbp:pregnancyCategory |
D (US)
|
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:sideEffect |
nausea
vomiting constipation fatigue neutropenia |
| gptkbp:usedFor |
gptkb:non-small_cell_lung_cancer
metastatic breast cancer |
| gptkbp:bfsParent |
gptkb:Vinorelbine
gptkb:vinorelbine |
| gptkbp:bfsLayer |
7
|